Company intelligence / Profile preview

Fresh Wind Biotechnologies

Missouri City, Texas, United Statesfreshwindbiotech.com ↗

Ownership: Private
Employees: ~50
Development stage: Preclinical

Overview

Fresh Wind Biotechnologies is developing advanced cellular immunotherapies for cancer, focusing on next-generation tumor-infiltrating lymphocyte manufacturing and organoid platforms. They also provide informatics services such as single-cell sequencing analysis. The company has published research on computational models for neoantigen prediction but does not yet have reported clinical trial results or approved therapies.[2][6][8][10]

Therapeutic areas: Oncology
Modalities: Cellular immunotherapies (notably Tumor-Infiltrating Lymphocytes, TILs)Organoid-based assays and co-culture systems[2][6][8]
Industry: Biotech

Beyond the preview

Go deeper on Fresh Wind Biotechnologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fresh Wind Biotechnologies.

Explore the full profile